All Articles

Mineralys Therapeutics' Lorundrostat shows promise in reducing heart failure risk, a breakthrough for millions struggling with uncontrolled hypertension.

With expanded coverage for 52 million Americans, Tonix Pharmaceuticals' TONMYA® is not just a drug launch; it's a market disruption for chronic pain.

Kymera Therapeutics' new lupus data isn't just about a drug. It's about a new strategy: erasing disease-causing proteins to build resilient value.

Beyond the gridlock in Meriden lies a story of strategic ambition. A look at how Parsons' engineering and a massive state investment aim to redefine a vital corridor.

Trane Technologies' latest report shows it's not just cutting emissions but building a profitable business model around it. A deep dive into their strategy.

Ares Capital, a giant in middle-market finance, just opened a new $1B funding spigot. Is this a blueprint for the BDC industry or a sign of cheaper capital for American businesses?

How new high-resolution analysis at Canadian GoldCamps' flagship project is de-risking a complex deposit and revealing its true high-grade potential.

Following its acquisition by Pearl Street Equity, Famous Brands brings in Richard Screnci to apply his QSR playbook to the iconic dessert franchises.

A routine board appointment at Bitcoin firm Twenty One Capital masks a major power shift. As Tether buys out SoftBank, is this a move toward legitimacy or a quiet coup?

With $173 million pouring into its tokenized SpaceX offering, MEXC is blurring the lines between crypto and Wall Street. But are retail investors buying a ticket to the moon or just a reflection of the rocket?

With a new CMO known for getting drugs approved, Protego Biopharma is betting big on its novel approach to treating a devastating rare disease.

A CPG veteran launches Lioness, a functional gummy snack for women. Can timed ingredients and a massive retail launch redefine the wellness market?

A new Texas hub isn't just about moving boxes. It's a strategic play to manage the complex, high-stakes lifecycle of hyperscale and AI infrastructure.

EQT appoints M&A mastermind Gustav Segerberg as CFO, signaling a doubling-down on its aggressive growth strategy. What does this mean for its future?

A Mumbai-based EdTech firm has assembled a team of global publishing and tech titans. This isn't just a board; it's a strategic play to write the rules for the AI-driven future of learning.

As Einride finalizes its public debut, a new partnership with Scan Sverige to electrify refrigerated freight signals a major breakthrough for the industry.

A Chinese medical device company just won top honors from global investors. It's not just a trophy—it's a masterclass in corporate strategy and global ambition.

A new partnership between PAM Health and Marshall Health Network isn't just building a hospital; it's creating a new healthcare and economic hub for South Point.

As FACE Coalition’s Melamoon tour lands in Halifax, it's clear this is more than a pitch contest. It’s a strategic move to dismantle systemic barriers.

A silent demographic cliff threatens trillions in assets. With 75% of advisors unprepared for transition, a new framework argues for legacy over exit.